Triple

T15982937
Position Surface form Disambiguated ID Type / Status
Subject Ariad Pharmaceuticals E387618 entity
Predicate brigatinibBrandName P121157 FINISHED
Object Alunbrig
Alunbrig is a targeted cancer therapy drug (brigatinib) used primarily to treat certain types of ALK-positive non-small cell lung cancer.
E1188113 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Alunbrig | Statement: [Ariad Pharmaceuticals, brigatinibBrandName, Alunbrig]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Alunbrig
Context triple: [Ariad Pharmaceuticals, brigatinibBrandName, Alunbrig]
  • A. Alaior
    Alaior is a historic inland town and municipality on the Spanish island of Menorca, known for its traditional architecture and local cheese production.
  • B. Rairok
    Rairok is a small islet and community area within the Marshall Islands' capital atoll of Majuro.
  • C. Braelangwell
    Braelangwell is a historic Highland estate in Scotland that served as the ancestral seat of Clan Urquhart.
  • D. Atlanersa
    Atlanersa was a Kushite king of the Napatan period who ruled Nubia in the 7th century BCE and continued the cultural and religious traditions of the earlier 25th Dynasty pharaohs.
  • E. Abron
    Abron is a Niger-Congo language spoken primarily by the Abron (Brong) people in parts of Ghana and Côte d'Ivoire.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Alunbrig
Triple: [Ariad Pharmaceuticals, brigatinibBrandName, Alunbrig]
Generated description
Alunbrig is a targeted cancer therapy drug (brigatinib) used primarily to treat certain types of ALK-positive non-small cell lung cancer.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Alunbrig
Target entity description: Alunbrig is a targeted cancer therapy drug (brigatinib) used primarily to treat certain types of ALK-positive non-small cell lung cancer.
  • A. Alaior
    Alaior is a historic inland town and municipality on the Spanish island of Menorca, known for its traditional architecture and local cheese production.
  • B. Rairok
    Rairok is a small islet and community area within the Marshall Islands' capital atoll of Majuro.
  • C. Braelangwell
    Braelangwell is a historic Highland estate in Scotland that served as the ancestral seat of Clan Urquhart.
  • D. Atlanersa
    Atlanersa was a Kushite king of the Napatan period who ruled Nubia in the 7th century BCE and continued the cultural and religious traditions of the earlier 25th Dynasty pharaohs.
  • E. Abron
    Abron is a Niger-Congo language spoken primarily by the Abron (Brong) people in parts of Ghana and Côte d'Ivoire.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: brigatinibBrandName
Context triple: [Ariad Pharmaceuticals, brigatinibBrandName, Alunbrig]
  • A. isProdrugOf
    Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
  • B. sponsorDrugBrand
    Indicates that one entity financially supports, endorses, or promotes a specific drug brand, typically in a commercial or regulatory context.
  • C. isIndicatedAsMonotherapyFor
    Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
  • D. fareBrand
    Indicates the specific fare category or brand under which a ticket or booking is sold, defining its associated rules, benefits, and restrictions.
  • E. hasMolecularTarget
    Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
  • F. None of above. chosen

Provenance (7 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e17d4d08f481909f38b75e3f42d9ab completed April 17, 2026, 12:22 a.m.
NED1 Entity disambiguation (via context triple) batch_69ffc3cdf7848190848e9081027dc027 completed May 9, 2026, 11:31 p.m.
NEDg Description generation batch_69ffc5669c1c81909bacf61c96cb7816 completed May 9, 2026, 11:38 p.m.
NED2 Entity disambiguation (via description) batch_69ffc5c7db1c8190b4e1de6f6e3ce8a0 completed May 9, 2026, 11:39 p.m.
PD Predicate disambiguation batch_69e142d9d8e881909b559a3e3ca21d24 completed April 16, 2026, 8:13 p.m.
PDg Predicate description generation batch_69e17d48cc9c8190b03fd07ae2e9dfd8 completed April 17, 2026, 12:22 a.m.
Created at: April 10, 2026, 4:54 a.m.